LFVN

+ Watchlist + Portfolio

Lifevantage Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $6.50
52-Week Range: $3.90 – $14.28
Market Cap: $83.90M
P/E (TTM): 14.78
EPS (TTM): 0.45
Dividend Yield: 3.07%

Advanced Metrics

Price/Book: 2.52
PEG Ratio: 0.36
Return on Equity: 17.08%
Return on Assets: 6.44%
Gross Margin: 78.14%
Operating Margin: 4.07%
Profit Margin: 2.94%
Current Ratio: 1.96
Debt/Equity: 0.31
Total Debt: $10.21M
Free Cash Flow: $2.03M
Revenue Growth: -25.20%
Earnings Growth: -58.50%
Enterprise Value: $79.73M

LFVN Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$206.36M	$213.40M	$200.16M	$228.53M
Cost of Revenue	$38.10M	$43.39M	$41.44M	$44.86M
Gross Profit	$168.26M	$170.01M	$158.72M	$183.67M
Selling, General & Admin	$63.42M	$71.06M	$68.47M	$69.21M
Operating Expenses	$160.69M	$165.75M	$154.39M	$171.47M
Operating Income	$7.58M	$4.26M	$4.33M	$12.20M
EBITDA	$7.96M	$7.84M	$7.91M	$15.36M
Pretax Income	$4.69M	$4.00M	$4.35M	$12.24M
Income Tax	$1.57M	$1.46M	$1.41M	$2.44M
Net Income	$3.12M	$2.54M	$2.94M	$9.80M
Diluted EPS	0.24	0.20	0.23	—
Diluted Shares	13.07M	12.57M	12.99M	—

LFVN Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$20.19M	$21.61M	$16.89M	$20.20M
Receivables	$5.09M	$1.85M	$3.26M	$3.93M
Inventory	$16.47M	$16.07M	$15.05M	$20.67M
Current Assets	$46.96M	$44.28M	$37.65M	$50.89M
Total Assets	$70.71M	$66.12M	$60.30M	$71.96M
Current Liabilities	$25.73M	$19.61M	$22.31M	$27.22M
Total Debt	$15.76M	$13.09M	$13.61M	$11.68M
Total Liabilities	$39.19M	$31.47M	$34.31M	$37.32M
Retained Earnings	-$98.44M	-$98.31M	-$108.74M	-$104.15M
Shareholders' Equity	$31.52M	$34.65M	$25.99M	$34.64M
Working Capital	$21.23M	$24.68M	$15.34M	$23.68M

LFVN Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$7.96M	$6.83M	$12.20M	$11.88M
Capital Expenditure	-$1.53M	-$3.07M	-$2.25M	-$1.37M
Free Cash Flow	$6.43M	$3.76M	$9.95M	$10.51M
Depreciation & Amortisation	$3.26M	$3.58M	$3.58M	$3.16M
Stock-Based Compensation	$1.77M	$3.19M	$3.28M	$5.70M
Investing Cash Flow	-$1.53M	-$3.06M	-$2.25M	-$1.37M
Financing Cash Flow	-$8.95M	-$2.36M	-$14.42M	-$7.60M
Dividends Paid	-$378.00K	-$1.59M	-$6.94M	-$2.07M
Share Repurchases	-$9.08M	-$1.02M	-$7.65M	-$5.81M
Net Change in Cash	-$2.52M	$1.41M	-$4.46M	$2.91M

LFVN Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$58.44M	$55.11M	$47.56M	$48.93M	$43.72M
Cost of Revenue	$11.11M	$11.06M	$9.74M	$12.72M	$9.17M
Gross Profit	$47.33M	$44.05M	$37.82M	$36.21M	$34.54M
Selling, General & Admin	$17.07M	$18.68M	$14.85M	$15.83M	$13.87M
Operating Expenses	$43.27M	$41.90M	$35.55M	$35.72M	$32.87M
Operating Income	$4.05M	$2.15M	$2.27M	$487.00K	$1.68M
EBITDA	$4.86M	$2.90M	$2.88M	$1.24M	$2.39M
Pretax Income	$4.18M	$2.40M	$2.24M	$473.00K	$1.66M
Income Tax	$710.00K	$437.00K	$86.00K	$197.00K	$294.00K
Net Income	$3.47M	$1.96M	$2.15M	$276.00K	$1.36M
Diluted EPS	0.26	0.15	0.17	0.02	0.11
Diluted Shares	13.30M	13.13M	12.95M	12.74M	12.66M

LFVN Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$22.47M	$20.20M	$13.09M	$10.18M	$12.48M
Receivables	$3.24M	$3.93M	$7.72M	$4.98M	$4.62M
Inventory	$22.22M	$20.67M	$20.59M	$18.98M	$18.38M
Current Assets	$54.11M	$50.89M	$45.05M	$38.56M	$39.31M
Total Assets	$77.24M	$71.96M	$61.58M	$61.17M	$62.13M
Current Liabilities	$32.58M	$27.22M	$18.83M	$19.01M	$20.10M
Total Debt	$12.36M	$11.68M	$11.19M	$10.69M	$10.21M
Total Liabilities	$43.23M	$37.32M	$28.42M	$28.18M	$28.79M
Retained Earnings	-$103.51M	-$104.15M	-$103.14M	-$103.44M	-$103.66M
Shareholders' Equity	$34.01M	$34.64M	$33.16M	$32.99M	$33.34M
Working Capital	$21.53M	$23.68M	$26.22M	$19.54M	$19.21M

LFVN Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$2.23M	$1.03M	-$2.31M	$2.79M	$4.99M
Capital Expenditure	-$331.00K	-$199.00K	-$439.00K	-$1.08M	-$1.01M
Free Cash Flow	$1.90M	$835.00K	-$2.74M	$1.71M	$3.98M
Depreciation & Amortisation	$803.00K	$750.00K	$610.00K	$752.00K	$714.00K
Stock-Based Compensation	$1.52M	$1.54M	$826.00K	$553.00K	$704.00K
Investing Cash Flow	-$331.00K	-$199.00K	-$439.00K	-$4.83M	-$1.01M
Financing Cash Flow	-$1.13M	-$3.24M	-$4.30M	-$738.00K	-$1.60M
Dividends Paid	-$503.00K	-$562.00K	-$571.00K	-$575.00K	-$573.00K
Share Repurchases	$1.25M	-$4.70M	-$3.86M	-$163.00K	$2.44M
Net Change in Cash	$770.00K	-$2.41M	-$7.04M	-$2.77M	$2.38M

Market Snapshot

About

LifeVantage Corporation is a wellness company that focuses on nutrigenomics, the study of how nutrition and naturally occurring compounds affect genes. The company develops and distributes science-based products including dietary supplements, skin care, and wellness solutions. LifeVantage markets its products through a direct selling network of independent distributors globally.